PRINCIPLE OF THE ASSAY
This assay employs the quantitative competitive enzyme immunoassay technique. Recombinant Human CD25 has been pre-coated onto a microplate. Standards or samples are premixed with biotin-labeled antibody and then pipetted into the wells. Basiliximab in the sample competitively binds to the pre-coated protein with biotin-labeled Basiliximab. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in inversely proportion to the amount of Basiliximab bound in the initial step. The color development is stopped and the intensity of the color is measured.
Stability and Storage | When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. For unopened kits, if you want to prolong the storage time, please store the Standard, Detection A, Detection B and Microplate at - 20 ℃, the rest reagents should be store at 4℃. |
Detection method | Colorimetric |
Sample type | Plasma, Serum |
Assay type | Quantitative |
Sensitivity | 13.31 ng/mL |
Range | 23.44 - 1,500 ng/mL |
Recovery | 80-120% |
Background | Basiliximab is a chimeric anti-intcrleukin-2 receptor monoclonal antibody. Basiliximab is a glycoprotein produced by recombinant technology. It is used to prevent white blood cells from acute renal transplantation rejection. It specifically binds to and blocks the alpha chain of interleukin-2 receptors (IL-2R alpha), also known as CD25 antigen, on the surface of activated T-lymphocytes. Due to its monoclonal nature it provides safer and more predictable therapeutic, that is, immunosuppressive response of the polyclonal antibodies. The most common adverse effects in adult patients are constipation, infections, pain, nausea, peripheral oedema, hypertension, anaemia, headache, hyperkalacmia, hypercholesterolemia, increase in serum creatinine, and hypophosphataemia. |
Alternative Names | CHI621, CHI-621 / SDZ-CHI-621, CAS: 179045-86-4 |
Shipping | 2-8 ℃ |
Specifications | Basiliximab |
Note | For Research Use Only. |